home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Arresting HIV

 
  March, 2 2004 9:56
your information resource in human molecular genetics
 
     
Researchers may now know why Old World monkeys are resistant to the disease-causing effects of the human immunodeficiency virus type 1 (HIV-1). The discovery may pave the way for new anti-HIV therapies.

Old World monkeys can become infected with HIV, but the RNA virus never gets converted to DNA and so is not incorporated into the host genome. The conversion is blocked by a protein called TRIM5alpha, Joseph Sodroski and colleagues report in Nature (26 February 2004, Vol. 427, No. 6977, pp. 848-853). The team report that the blocking factor works less well against the monkey version of HIV, simian immunodeficiency virus (SIV), which may explain why Old World monkeys fall foul of SIV but are resistant to HIV.

"The work uncovers key players in the early steps of virus replication, and may lead to new approaches in inhibiting HIV-1," says Stephen P. Goff in an accompanying News and Views article.

CONTACT:

Joseph Sodroski
Dana-Farber Cancer Institute
Boston, MA
USA
Tel: +1 617 632 3371
E-mail: joseph_sodroski@dfci.harvard.edu

Stephen P. Goff
HHMI
Columbia University
New York, NY
USA
Tel: +1 212 305 3794
E-mail: Goff@cuccfa.ccc.columbia.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.